Andrew C. Morton - 01 Mar 2022 Form 4 Insider Report for NUVASIVE INC

Reporting relationship: SVP, CHRO
Issuer ticker: N/A
Reported as of: 01 Mar 2022
Net transaction value: $0
SEC form: 4
Accepted by SEC: 03 Mar 2022, 16:54:07 UTC
Prior SEC filing: 14 Feb 2022
Source filing: View source filing
Reporting owner signature: s/ Nathaniel B. Sisitsky, Attorney-in-fact for Andrew C. Morton

Key filing fact

Andrew C. Morton filed Form 4 for NUVASIVE INC on 03 Mar 2022.

Key facts

This page summarizes Andrew C. Morton's Form 4 filing for NUVASIVE INC.
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 03 Mar 2022, 16:54.

Change

Previous filing in this sequence was filed on 14 Feb 2022.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

NUVA transaction Derivative

RSUs

Award

Transaction value: $0
Shares: +6,421
Change %
Price: $0.000000
Shares after: 6,421
Date: 01 Mar 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 6,421
Exercise price: $0.000000
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's common stock upon vesting.

Footnote F2

This RSU award was granted to the Reporting Person on March 1, 2022. In accordance with the terms of the RSU award, the award will vest in full on March 1, 2025.